AI in Radiotherapy Target oncology clinics and radiation therapy centers that are seeking AI-powered decision support to improve treatment planning and outcomes, highlighting Siris Medical’s QuickMatch and PlanMD as scalable solutions with 510(k) clearance.

Growing Library Position as a data-driven advantage for customers by emphasizing access to a growing library of plan outcomes that connects each new patient to proven treatment results, supporting evidence-based decision making.

Early-stage Advantage Engage smaller to mid-size radiotherapy centers and academic clinics that can benefit from cutting-edge AI tools without large legacy systems, leveraging Siris Medical’s nimble deployment and regulatory clearance.

Strategic Partnerships Pursue collaborations with established medical device and imaging companies seeking to augment their portfolio with AI decision-support capabilities or to accelerate adoption in radiotherapy workflows.

Expansion Signals Leverage recent product updates and historical financing milestones to create outreach around product maturity, continued R&D, and potential expansion into adjacent cancer treatment decision-support markets.